XML 60 R43.htm IDEA: XBRL DOCUMENT v3.3.1.900
INTANGIBLE ASSETS (Details ) - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Finite-Lived Intangible Assets    
Accumulated Amortization $ (146,081) $ (113,640)
Indefinite-Lived Intangible Assets    
Gross Carrying Amount 1,761,332 1,342,228
Net Amount 1,615,251 1,228,588
Hormone therapy drug candidate patents - In Process [Member]    
Indefinite-Lived Intangible Assets    
Gross Carrying Amount 774,165 675,982
Net Amount 774,165 675,982
Multiple trademarks for vitamins/supplements [Member]    
Indefinite-Lived Intangible Assets    
Gross Carrying Amount 157,721 103,368
Net Amount 157,721 103,368
OPERA software patent [Member]    
Finite-Lived Intangible Assets    
Gross Carrying Amount 31,951 31,951
Accumulated Amortization (3,994) (2,496)
Net Amount $ 27,957 $ 29,455
Weighted average remaining amortization period 13 years 9 months 14 years 9 months
Development costs for corporate website [Member]    
Finite-Lived Intangible Assets    
Gross Carrying Amount $ 91,743 $ 91,743
Accumulated Amortization $ (91,743) $ (91,743)
Net Amount
Approved Hormone Therapy Drug Candidate Patents [Member]    
Finite-Lived Intangible Assets    
Gross Carrying Amount $ 705,752 $ 439,184
Accumulated Amortization (49,845) (19,401)
Net Amount $ 655,907 $ 419,783
Weighted average remaining amortization period 17 years 18 years